ERBB2 and breast cancer: In addition, we noticed that the expression levels of CDYL2b were significantly lower in the majority of TNBC cell lines (with the exception of BT20 cell line) than those in luminal and HER2-positive breast cancer cell lines 42 (Figure 1A).